0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Case report: A Saprochaete clavata ( Magnusiomyces clavatus) severe infection effectively treated with granulocyte transfusion in a young patient with myeloid sarcoma

      case-report

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Myeloid sarcoma is a hematologic malignancy consisting of extramedullary tissue involvement by myeloid blasts, usually considered as acute myeloid leukemia and treated accordingly. The disease itself, together with chemotherapy and disease-associated factors, may have an impact in increasing the risk of developing severe and frequently life-threatening infections. Herein, we describe the case of a patient with a right breast skin lesion, histologically diagnosed myeloid sarcoma, who developed a severe disseminated fungal infection by Saprochaete clavata ( Magnusiomyces clavatus), during the first consolidation course of chemotherapy. Despite maximum antifungal therapy, the infection progressed and the fungus continued to be isolated until granulocyte transfusion therapy was initiated. Our experience suggests that patients with profound and long-lasting neutropenia could benefit from granulocyte transfusions as additional therapy in severe fungal infections resistant to broad-spectrum antimicrobial therapy.

          Related collections

          Most cited references26

          • Record: found
          • Abstract: found
          • Article: not found

          Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel.

          The first edition of the European LeukemiaNet (ELN) recommendations for diagnosis and management of acute myeloid leukemia (AML) in adults, published in 2010, has found broad acceptance by physicians and investigators caring for patients with AML. Recent advances, for example, in the discovery of the genomic landscape of the disease, in the development of assays for genetic testing and for detecting minimal residual disease (MRD), as well as in the development of novel antileukemic agents, prompted an international panel to provide updated evidence- and expert opinion-based recommendations. The recommendations include a revised version of the ELN genetic categories, a proposal for a response category based on MRD status, and criteria for progressive disease.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Acute Myeloid Leukemia.

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet.

              In 2003, an international working group last reported on recommendations for diagnosis, response assessment, and treatment outcomes in acute myeloid leukemia (AML). Since that time, considerable progress has been made in elucidating the molecular pathogenesis of the disease that has resulted in the identification of new diagnostic and prognostic markers. Furthermore, therapies are now being developed that target disease-associated molecular defects. Recent developments prompted an international expert panel to provide updated evidence- and expert opinion-based recommendations for the diagnosis and management of AML, that contain both minimal requirements for general practice as well as standards for clinical trials. A new standardized reporting system for correlation of cytogenetic and molecular genetic data with clinical data is proposed.
                Bookmark

                Author and article information

                Contributors
                Journal
                Front Oncol
                Front Oncol
                Front. Oncol.
                Frontiers in Oncology
                Frontiers Media S.A.
                2234-943X
                15 September 2022
                2022
                : 12
                : 970188
                Affiliations
                [1] 1Hematology, Department of Biomedicine and Prevention, Università degli studi di Roma Tor Vergata , Rome, Italy
                [2] 2Institute of Translational Pharmacology, Department of Biomedical Sciences, National Research Council (CNR) , Rome, Italy
                Author notes

                Edited by: Francesco Onida, IRCCS Ca ‘Granda Foundation Maggiore Policlinico Hospital, Italy

                Reviewed by: Gioacchino Andrea Rotulo, Bambino Gesù Children’s Hospital (IRCCS), Italy; Arash Heidari, Kern Medical Center, United States

                *Correspondence: Giuseppe Sconocchia, giuseppe.sconocchia@ 123456ift.cnr.it

                This article was submitted to Hematologic Malignancies, a section of the journal Frontiers in Oncology

                Article
                10.3389/fonc.2022.970188
                9521543
                8219af8a-4662-426a-8de4-88f78e9867bd
                Copyright © 2022 Pasqualone, Buzzatti, Palmieri, Savi, Pascale, Borsellino, Guarnera, Buccisano, Voso, Maurillo, Sconocchia, Venditti and Del Principe

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 15 June 2022
                : 19 August 2022
                Page count
                Figures: 2, Tables: 0, Equations: 0, References: 26, Pages: 7, Words: 3067
                Funding
                Funded by: Associazione Italiana per la Ricerca sul Cancro , doi 10.13039/501100005010;
                Categories
                Oncology
                Case Report

                Oncology & Radiotherapy
                acute myeloid leukemia,invasive fungal infection,granulocyte transfusion,saprochaeta clavata,magnusiomyces clavatus,case report,myeloid sarcoma (ms)

                Comments

                Comment on this article